ATE227724T1 - Muscarinagonisten und antagonisten - Google Patents

Muscarinagonisten und antagonisten

Info

Publication number
ATE227724T1
ATE227724T1 AT99945064T AT99945064T ATE227724T1 AT E227724 T1 ATE227724 T1 AT E227724T1 AT 99945064 T AT99945064 T AT 99945064T AT 99945064 T AT99945064 T AT 99945064T AT E227724 T1 ATE227724 T1 AT E227724T1
Authority
AT
Austria
Prior art keywords
muscarinagonists
antagonists
Prior art date
Application number
AT99945064T
Other languages
English (en)
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
George Mark Latham
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE227724T1 publication Critical patent/ATE227724T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT99945064T 1998-08-18 1999-08-16 Muscarinagonisten und antagonisten ATE227724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
ATE227724T1 true ATE227724T1 (de) 2002-11-15

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945064T ATE227724T1 (de) 1998-08-18 1999-08-16 Muscarinagonisten und antagonisten

Country Status (30)

Country Link
US (5) US6093724A (de)
EP (1) EP1112272B1 (de)
JP (1) JP2002523416A (de)
KR (1) KR20010072784A (de)
CN (1) CN1312812A (de)
AR (1) AR020199A1 (de)
AT (1) ATE227724T1 (de)
AU (1) AU750566B2 (de)
BG (1) BG105256A (de)
BR (1) BR9913072A (de)
CA (1) CA2340946A1 (de)
CO (1) CO5130018A1 (de)
DE (1) DE69903961T2 (de)
EE (1) EE200100096A (de)
ES (1) ES2191455T3 (de)
HK (1) HK1038918A1 (de)
HU (1) HUP0103203A3 (de)
ID (1) ID27544A (de)
IL (1) IL141050A0 (de)
IS (1) IS5827A (de)
NO (1) NO20010804L (de)
NZ (1) NZ509762A (de)
PE (1) PE20000988A1 (de)
PL (1) PL346247A1 (de)
RU (1) RU2219179C2 (de)
SK (1) SK1892001A3 (de)
TR (1) TR200100462T2 (de)
WO (1) WO2000011001A1 (de)
YU (1) YU13301A (de)
ZA (1) ZA200100978B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031013A3 (en) * 2000-10-19 2004-03-17 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (de) * 2007-03-23 2012-09-12 Abbott Laboratories 4-substituierte Azaadamantan-Derivate und Verfahren zu ihrer Verwendung
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2619205B1 (de) * 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrat eines azaadamantanderivates
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3651762B1 (de) 2017-07-12 2024-07-03 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
JP7270989B2 (ja) 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体m4のアンタゴニスト
EP3732163A4 (de) * 2017-12-20 2021-07-14 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
PT3856182T (pt) 2018-09-28 2026-03-10 Karuna Therapeutics Inc Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク シヤープ エンド ドーム リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
TR199800780T2 (xx) * 1995-11-02 1998-07-21 Neurosearch A/S Kayna�m�� tropan t�revleri, haz�rlan��lar� ve kullan�mlar�.
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
CO5130018A1 (es) 2002-02-27
BR9913072A (pt) 2001-05-15
TR200100462T2 (tr) 2001-09-21
US6323194B1 (en) 2001-11-27
US6251916B1 (en) 2001-06-26
HK1038918A1 (zh) 2002-04-04
ZA200100978B (en) 2002-02-05
PE20000988A1 (es) 2000-09-30
KR20010072784A (ko) 2001-07-31
EP1112272B1 (de) 2002-11-13
EE200100096A (et) 2002-06-17
ES2191455T3 (es) 2003-09-01
DE69903961T2 (de) 2003-07-03
WO2000011001A1 (en) 2000-03-02
US20020045617A1 (en) 2002-04-18
NZ509762A (en) 2002-12-20
SK1892001A3 (en) 2001-11-06
DE69903961D1 (de) 2002-12-19
IS5827A (is) 2001-01-26
ID27544A (id) 2001-04-12
RU2219179C2 (ru) 2003-12-20
US6555550B1 (en) 2003-04-29
JP2002523416A (ja) 2002-07-30
US6093724A (en) 2000-07-25
AR020199A1 (es) 2002-05-02
NO20010804L (no) 2001-04-11
YU13301A (sh) 2005-06-10
EP1112272A1 (de) 2001-07-04
HUP0103203A3 (en) 2002-10-28
IL141050A0 (en) 2002-02-10
NO20010804D0 (no) 2001-02-16
US6423842B1 (en) 2002-07-23
CN1312812A (zh) 2001-09-12
HUP0103203A2 (hu) 2002-01-28
AU750566B2 (en) 2002-07-25
CA2340946A1 (en) 2000-03-02
PL346247A1 (en) 2002-01-28
AU5775899A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
DE69913169D1 (de) Sportschuh und dafür vorgesehene dornen
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
DE69932265D1 (de) Musikaktionsspielsystem und computerlesbare Aufzeichnungsvorrichtung
DE69924002D1 (de) Kompressions-abgestimmtes bragggitter und kompressions-abgestimmter laser
DE69903961D1 (de) Muscarinagonisten und antagonisten
DE69921723D1 (de) USB-Vorrichtung und USB- Knotenpunktvorrichtung
EP0986385A4 (de) Antagonisten des gonadorelins
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
ATE351907T1 (de) Selective il-2 agonisten und antagonisten
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
DE69823876D1 (de) Induktives bauelement und induktive bauelementanordnung
DE50112013D1 (de) Deodorantien und antiperspirantien
DE69738197D1 (de) Azolotriazine und pyrimidine
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE19983771T1 (de) Elektrochrome Gebilde und Strukturen
NO20005503L (no) Ny anvendelse
ID26599A (id) Turunan triazola dan imidazola
DE69831750D1 (de) Biozide und biozide tücher
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE59904577D1 (de) Metallocenkomplexe
ID28852A (id) Bahan-bahan elektroluminesensi
ID23083A (id) Popok sekali pakai

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties